EVERSANA Acquires HVH Precision Analytics

EVERSANA Acquires Protean

October 15, 2021

Healthcare Services

EVERSANA has acquired Protean, a market access consulting firm that specializes in channel and trade, patient services and payer contracting operations. The deal integrates Protean’s operational experts and proprietary tools into EVERSANA’s consulting and commercial services to expand market access, channel and patient services capabilities for life sciences clients.

EVERSANA Acquires Alkemy Partners

September 9, 2020

Healthcare Services

EVERSANA, a Chicago-based provider of commercial services to the life science industry, has acquired Alkemy Partners, a New Hampshire–based field learning and development firm that provides training, content creation and digital solutions for market access, sales and clinical engagement. The deal expands EVERSANA's field solutions and training capabilities — adding medical writing, training facilitation, leadership development and multimedia/digital learning capabilities to its commercial services platform. Financial terms were not disclosed.

EVERSANA Acquires Healthware Group

October 11, 2023

Marketing & Advertising

EVERSANA has acquired Healthware Group, a Salerno-headquartered full-service healthcare agency and innovation consultancy, expanding EVERSANA's European operations and integrating Healthware into its EVERSANA INTOUCH global agency network. Healthware (150+ employees) will bring marketing, medical communications, digital innovation, and media assets — including the Frontiers Health conference and pharmaphorum — into EVERSANA; Roberto Ascione joins EVERSANA's global leadership. Financial terms were not disclosed.

EVERSANA Merges with Waltz Health

August 26, 2025

Healthcare Services

EVERSANA announced a merger with Waltz Health to combine EVERSANA’s end-to-end pharmaceutical commercialization services with Waltz’s AI-driven prescription routing and payer-facing marketplace technology. Mark Thierer, co-founder and CEO of Waltz Health, will serve as CEO of the combined organization as the companies integrate capabilities to improve drug affordability, payer connectivity and patient access for specialty and high-cost therapies.

EVERSANA Acquires Cornerstone Research Group

October 30, 2019

Healthcare Services

EVERSANA has agreed to acquire Canada-based Cornerstone Research Group, a health economics and outcomes research (HEOR) firm headquartered in Burlington, Ontario. The acquisition adds HEOR, economic modeling, evidence synthesis and market access capabilities to EVERSANA’s integrated commercial services platform to better support pharmaceutical and medical device clients globally.

EVERSANA Acquires Intouch Group

December 21, 2021

Marketing & Advertising

EVERSANA has completed its acquisition of Intouch Group, a global full-service agency network serving the pharmaceutical industry. The deal integrates Intouch’s creative, media, enterprise solutions and data analytics into EVERSANA’s commercialization services platform to expand capabilities and accelerate digital-first commercialization for life sciences clients.